What is the global market size of 3D Cell Culture Market?

Global 3D Cell Culture Market size was valued at USD 1.12 billion in 2021 and is poised to grow from USD 1.3 billion in 2022 to USD 4.77 billion by 2030, growing at a CAGR of 15.6% in the forecast period (2023-2030).

What is the key driver of Global 3D Cell Culture Market?

The increasing prevalence of chronic diseases, such as diabetes and kidney failure, has led to a rise in demand for organ transplantation. However, there is a shortage of organs available for transplantation. 3D cell culture technology can be used to develop functional organs for transplantation, which is driving the growth of the market. For example, Organovo, a biotechnology company, has developed 3D printed liver tissues for use in drug testing and transplantation research.

What is the key market trend for Global 3D Cell Culture Market?

Growing focus on personalized medicine: There is an increasing focus on personalized medicine, which requires the development of patient-specific models for drug testing and disease modeling. 3D cell culture technology can be used to create patient-specific models that can be used for personalized drug discovery and treatment. For instance, Hubrecht Organoid Technology (HUB) has developed a platform that uses patient-derived organoids for drug testing and personalized medicine.

Which region accounted for the largest share in Global 3D Cell Culture Market?

North America held the largest market share of 45.58% in 2022. This was due to factors such as advanced healthcare infrastructure, developed economies, the presence of key players, and strategic initiatives undertaken by them. Additionally, a supportive regulatory framework, government support for the development of three-dimensional culture models, and numerous research organizations and universities investigating different stem-cell based approaches are expected to further boost the regional market. For instance, the Harvard Stem Cell Institute is utilizing stem cells to revolutionize medicine for better outcomes.

Global 3D Cell Culture Market Size, Share, Growth Analysis, By Products(Scaffold-Based, Scaffold-Free), By Application(Cancer Research, Stem Cell Research & Tissue Engineering), By End User(Biotechnology and Pharmaceutical Companies, Academic & Research Institutes) - Industry Forecast 2024-2031

Report ID: SQMIG35H2246 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 90 | Figures: 76

Global 3D Cell Culture Market Regional Insights

In 2022, North America held the largest share of the market, representing primarily propelled by the growing concentration of universities and research institutions in the region. Additionally, growing government initiatives and funding aimed at developing advanced 3D culture models are expected to further enhance the regional business environment. For Instance, in March 2023, the ALS Society of Canada (ALS Canada) partnered with Brain Canada to invest 1.4 million in supporting nine projects focused on groundbreaking discoveries and treatments for amyotrophic lateral sclerosis (ALS).

The Asia-Pacific market is poised for significant growth, driven by factors such as the increasing disease burden and the widespread adoption of 3D culture by biopharmaceutical industries for drug discovery, aiming to streamline drug development timelines. Additionally, the rising prevalence of diseases like diabetes and obesity further underscores the need for accelerated development of innovative and effective drugs, prompting companies to embrace 3D cell culture technologies. China's 3D cell culture market held the largest share in the region, while India's market emerged as the fastest growing.

Global 3D Cell Culture Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global 3D Cell Culture Market size was valued at USD 1.3 billion in 2022 and is poised to grow from USD 1.31 billion in 2023 to USD 11.79 billion by 2031, growing at a CAGR of 18.2% during the forecast period (2024-2031).

The global 3D cell culture market is characterized by intense competition and rapid evolution driven by ongoing innovations and the growing demand for semiconductor devices. Established industry leaders vie for market dominance through product excellence, technical breakthroughs, competitive pricing, and expansive global distribution networks. Sustained investments in research and development, coupled with the adoption of groundbreaking methodologies, serve as pivotal drivers of market leadership. ' Thermo Fisher Scientific Inc. (US) ', ' Corning Incorporated (US) ', ' Merck KGaA (Germany) ', ' Lonza Group AG (Switzerland) ', ' Becton, Dickinson and Company (US) ', ' 3D Biotek LLC (US) ', ' InSphero AG (Switzerland) ', ' Synthecon Inc. (US) ', ' Tecan Trading AG (Switzerland) ', ' PromoCell GmbH (Germany) ', ' Greiner Bio-One International GmbH (Austria) ', ' Avantor, Inc. (US) ', ' Sartorius AG (Germany) ', ' Nano3D Biosciences, Inc. (US) ', ' MIMETAS B.V. (Netherlands) ', ' QGel SA (Switzerland) ', ' TissUse GmbH (Germany) ', ' SynVivo, Inc. (US) ', ' Emulate, Inc. (US) ', ' CN Bio Innovations Ltd. (UK) '

3D cell culturing techniques comprising of a novel approach are going to be a new revolution in area of regenerative medicine, which facilitate development of sophisticated tissues structures mimicking natural environment. This ground-breaking innovation enables the investigation of tissue regeneration and engineering at a deeper level which brings it to the forefront of the medical research. Along with regenerative medicine, a new trend in the medical world, these advanced cell culture technologies, like bio-3D, get also more required. Therefore, this emerging technology drives the growth of 3D cell culture industry by providing the technologies which are highly specific for researchers and clinicians for understanding and implementation of regenerative therapies.

Advanced Cell Culture Technologies: The evolution of organ-on-a-chip and microfluidic systems has surged, offering more sophisticated 3D cell culture environments. These platforms enable researchers to replicate inter-organ and tissue interactions with greater precision. For Instance, in December 2022, Emulate, Inc., introduced the Emulate Chip-A1™ Accessible Chip via an early access initiative. This latest iteration builds upon the foundation of the original Chip-S1, which replicates tissue-vascular interfaces with pertinent biomechanical stimuli like stretch and flow. The Chip-A1™ enables users to cultivate thicker tissues within the epithelial culture chamber and implement a wider array of drug treatment methods, including topical or aerosolized applications, thereby enhancing versatility and experimentation options..

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.